Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, December 18, 2009, 12:39PM ET - U.S. Markets close in 3 hours and 21 minutes. Dow Down 0.05% Nasdaq Up 0.89%
IGENE Biotechnology Inc. (IGNE.PK)On Dec 17: 0.01   0.00 (0.00%)  
MORE ON IGNE.PK
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
IGENE Biotechnology Inc.
9110 Red Branch Road
Columbia, MD 21045-2024
United States - Map
Phone: 410-997-2599
Fax: 410-997-1392
Web Site: http://www.igene.com

DETAILS 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:18

BUSINESS SUMMARY 
IGENE Biotechnology, Inc. engages in the development, production, and marketing of specialty biochemical products in the United States and internationally. It focuses on research and development in the areas of fermentation technology, nutrition and health, and marketing of products and applications. The company offers AstaXin, a natural source of astaxanthin, a pigment that imparts the characteristic red color to the flesh of salmon, trout, prawns, and other types of fish and shellfish. It is also venturing to supply astaxanthin as a nutraceutical ingredient. The company sells AstaXin primarily to fish producers in the aquaculture industry principally in the European Union, Japan, Chile, and Canada. IGENE Biotechnology, Inc. has a joint venture agreement with Archer-Daniels-Midland Company to manufacture and sell astaxanthin and derivative products worldwide. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on IGENE Biotechnology Inc.


    CORPORATE GOVERNANCE 
    IGENE Biotechnology Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 1.7% of CGQ Universe companies and 1.7% of Materials companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. Stephen F. Hiu , 52
    Chief Exec. Officer, Pres, Chief Technical Officer, Director of R&D, Treasurer
    $ 163.00KN/A
    Mr. Edward J. Weisberger , 44
    Chief Financial Officer and Principal Accounting Officer
    $ 145.00KN/A
    Mr. Patrick F. Monahan , 58
    VP, Director of Manufacturing, Sec.
    $ 140.00KN/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis